Get startedLog in
    Picture of Bausch + Lomb logo

    BLCO — Bausch + Lomb Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Bausch + Lomb, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARSARSARS
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue3,4123,7653,7684,1464,791
    Cost of Revenue
    Gross Profit2,1272,2982,2492,5042,919
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses3,1523,4363,5614,0164,629
    Operating Profit260329207130162
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes29031873-166-234
    Provision for Income Taxes
    Net Income After Taxes-1719315-248-305
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-181826-260-317
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-181826-260-317
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.0350.5430.091-0.588-0.802
    Dividends per Share